Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for reducing transfusion after primary total hip replacement
ACTRN12610001065088Phase 4Completed
- Sponsor
- Dr James Blackett
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid in osteoarthritis (OA) and osteonecrosis of the hip, sponsored by Dr James Blackett. Started Aug 2011; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)osteonecrosis of the hip
Beyond the preview
Go deeper on ACTRN12610001065088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001065088.